VanEck is a global investment manager with offices around the world. To help you find content that is suitable for your investment needs, please select your country and investor type.
Trends with Benefits is a podcast by VanEck with a forward-looking perspective. Host Ed Lopez interviews a guest each week to discover new ways of thinking about the markets, investing, work and life.
Find all relevant documents regarding VanEck’s ETNs such as KIDs, Prospectuses and Final Terms.
Find general legal policies and procedures of VanEck such as the Remuneration Policy or Complaints Procedure.
Through forward-looking, intelligently designed active and ETF solutions, we offer value-added exposures to emerging industries, asset classes and markets as well as differentiated approaches to traditional strategies.
Search the latest job roles and career opportunities at VanEck. Apply today to join our growing European team.
Find the VanEck contact details for all European countries. If you have questions about our range of ETFs and mutual funds, please let us know.
The Morningstar Wide Moat Focus Index has historically posted excess returns in periods following months of underperformance, according to Morningstar. Will that hold true following this summer's slump?
As active managers continue to underperform U.S. equity benchmarks, we look at the importance of moats and valuations to the Morningstar® Wide Moat Focus IndexSM ’s performance and highlight its most undervalued constituents.
The latest quarterly review of the Morningstar Wide Moat Focus Index continues the key trends of the year: the shift away from big tech, tech and health care sector weight increases and an all-time high in value exposure.
The S&P 500 Index is positive for the year so far, despite more than half of its constituents posting negative total returns. Are certain sectors becoming far too overvalued?
The long standing healthcare overweight in the Morningstar Wide Moat Focus Index goes beyond patent protection to include the ability of large pharmaceutical and biotech companies to innovate.